Follow the 케어랩스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 케어랩스 has logged 64 reports. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 원익홀딩스. The full history is openly available.
64
Insider Decl.
n/a
Thresholds
n/a
41 ops.
Buy Volume
n/a
17 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Carelabs is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing technological solutions to enhance healthcare services.